Global PCSK9 Inhibitors Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PCSK9 Inhibitors Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for PCSK9 Inhibitors by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for PCSK9 Inhibitors by Country/Region, 2017, 2022 & 2028

2.2 PCSK9 Inhibitors Segment by Type

2.2.1 Epatha(Evolocumab)

2.2.2 Praluent(Alirocumab)

2.2.3 Bococizumab

2.2.4 Others

2.3 PCSK9 Inhibitors Sales by Type

2.3.1 Global PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

2.3.2 Global PCSK9 Inhibitors Revenue and Market Share by Type (2017-2022)

2.3.3 Global PCSK9 Inhibitors Sale Price by Type (2017-2022)

2.4 PCSK9 Inhibitors Segment by Application

2.4.1 Clinical Application

2.4.2 Drug Development

2.4.3 Other

2.5 PCSK9 Inhibitors Sales by Application

2.5.1 Global PCSK9 Inhibitors Sale Market Share by Application (2017-2022)

2.5.2 Global PCSK9 Inhibitors Revenue and Market Share by Application (2017-2022)

2.5.3 Global PCSK9 Inhibitors Sale Price by Application (2017-2022)

3 Global PCSK9 Inhibitors by Company

3.1 Global PCSK9 Inhibitors Breakdown Data by Company

3.1.1 Global PCSK9 Inhibitors Annual Sales by Company (2020-2022)

3.1.2 Global PCSK9 Inhibitors Sales Market Share by Company (2020-2022)

3.2 Global PCSK9 Inhibitors Annual Revenue by Company (2020-2022)

3.2.1 Global PCSK9 Inhibitors Revenue by Company (2020-2022)

3.2.2 Global PCSK9 Inhibitors Revenue Market Share by Company (2020-2022)

3.3 Global PCSK9 Inhibitors Sale Price by Company

3.4 Key Manufacturers PCSK9 Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PCSK9 Inhibitors Product Location Distribution

3.4.2 Players PCSK9 Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for PCSK9 Inhibitors by Geographic Region

4.1 World Historic PCSK9 Inhibitors Market Size by Geographic Region (2017-2022)

4.1.1 Global PCSK9 Inhibitors Annual Sales by Geographic Region (2017-2022)

4.1.2 Global PCSK9 Inhibitors Annual Revenue by Geographic Region

4.2 World Historic PCSK9 Inhibitors Market Size by Country/Region (2017-2022)

4.2.1 Global PCSK9 Inhibitors Annual Sales by Country/Region (2017-2022)

4.2.2 Global PCSK9 Inhibitors Annual Revenue by Country/Region

4.3 Americas PCSK9 Inhibitors Sales Growth

4.4 APAC PCSK9 Inhibitors Sales Growth

4.5 Europe PCSK9 Inhibitors Sales Growth

4.6 Middle East & Africa PCSK9 Inhibitors Sales Growth

5 Americas

5.1 Americas PCSK9 Inhibitors Sales by Country

5.1.1 Americas PCSK9 Inhibitors Sales by Country (2017-2022)

5.1.2 Americas PCSK9 Inhibitors Revenue by Country (2017-2022)

5.2 Americas PCSK9 Inhibitors Sales by Type

5.3 Americas PCSK9 Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PCSK9 Inhibitors Sales by Region

6.1.1 APAC PCSK9 Inhibitors Sales by Region (2017-2022)

6.1.2 APAC PCSK9 Inhibitors Revenue by Region (2017-2022)

6.2 APAC PCSK9 Inhibitors Sales by Type

6.3 APAC PCSK9 Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe PCSK9 Inhibitors by Country

7.1.1 Europe PCSK9 Inhibitors Sales by Country (2017-2022)

7.1.2 Europe PCSK9 Inhibitors Revenue by Country (2017-2022)

7.2 Europe PCSK9 Inhibitors Sales by Type

7.3 Europe PCSK9 Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PCSK9 Inhibitors by Country

8.1.1 Middle East & Africa PCSK9 Inhibitors Sales by Country (2017-2022)

8.1.2 Middle East & Africa PCSK9 Inhibitors Revenue by Country (2017-2022)

8.2 Middle East & Africa PCSK9 Inhibitors Sales by Type

8.3 Middle East & Africa PCSK9 Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of PCSK9 Inhibitors

10.3 Manufacturing Process Analysis of PCSK9 Inhibitors

10.4 Industry Chain Structure of PCSK9 Inhibitors

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 PCSK9 Inhibitors Distributors

11.3 PCSK9 Inhibitors Customer

12 World Forecast Review for PCSK9 Inhibitors by Geographic Region

12.1 Global PCSK9 Inhibitors Market Size Forecast by Region

12.1.1 Global PCSK9 Inhibitors Forecast by Region (2023-2028)

12.1.2 Global PCSK9 Inhibitors Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global PCSK9 Inhibitors Forecast by Type

12.7 Global PCSK9 Inhibitors Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen PCSK9 Inhibitors Product Offered

13.1.3 Amgen PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 Eli Lilly

13.2.1 Eli Lilly Company Information

13.2.2 Eli Lilly PCSK9 Inhibitors Product Offered

13.2.3 Eli Lilly PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly Main Business Overview

13.2.5 Eli Lilly Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi PCSK9 Inhibitors Product Offered

13.3.3 Sanofi PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer PCSK9 Inhibitors Product Offered

13.4.3 Pfizer PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Novartis

13.5.1 Novartis Company Information

13.5.2 Novartis PCSK9 Inhibitors Product Offered

13.5.3 Novartis PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis Main Business Overview

13.5.5 Novartis Latest Developments

13.6 Roche

13.6.1 Roche Company Information

13.6.2 Roche PCSK9 Inhibitors Product Offered

13.6.3 Roche PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roche Main Business Overview

13.6.5 Roche Latest Developments

13.7 Merck

13.7.1 Merck Company Information

13.7.2 Merck PCSK9 Inhibitors Product Offered

13.7.3 Merck PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Main Business Overview

13.7.5 Merck Latest Developments

13.8 Alnylam

13.8.1 Alnylam Company Information

13.8.2 Alnylam PCSK9 Inhibitors Product Offered

13.8.3 Alnylam PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alnylam Main Business Overview

13.8.5 Alnylam Latest Developments

13.9 AstraZeneca

13.9.1 AstraZeneca Company Information

13.9.2 AstraZeneca PCSK9 Inhibitors Product Offered

13.9.3 AstraZeneca PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AstraZeneca Main Business Overview

13.9.5 AstraZeneca Latest Developments

13.10 Affiris

13.10.1 Affiris Company Information

13.10.2 Affiris PCSK9 Inhibitors Product Offered

13.10.3 Affiris PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Affiris Main Business Overview

13.10.5 Affiris Latest Developments

13.11 BMS

13.11.1 BMS Company Information

13.11.2 BMS PCSK9 Inhibitors Product Offered

13.11.3 BMS PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 BMS Main Business Overview

13.11.5 BMS Latest Developments

13.12 Ionis Pharmaceuticals

13.12.1 Ionis Pharmaceuticals Company Information

13.12.2 Ionis Pharmaceuticals PCSK9 Inhibitors Product Offered

13.12.3 Ionis Pharmaceuticals PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ionis Pharmaceuticals Main Business Overview

13.12.5 Ionis Pharmaceuticals Latest Developments

13.13 Cyon Therapeutics

13.13.1 Cyon Therapeutics Company Information

13.13.2 Cyon Therapeutics PCSK9 Inhibitors Product Offered

13.13.3 Cyon Therapeutics PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Cyon Therapeutics Main Business Overview

13.13.5 Cyon Therapeutics Latest Developments

13.14 Daiichi Sankyo

13.14.1 Daiichi Sankyo Company Information

13.14.2 Daiichi Sankyo PCSK9 Inhibitors Product Offered

13.14.3 Daiichi Sankyo PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Daiichi Sankyo Main Business Overview

13.14.5 Daiichi Sankyo Latest Developments

14 Research Findings and Conclusion

Table 1. PCSK9 Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. PCSK9 Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Epatha(Evolocumab)

Table 4. Major Players of Praluent(Alirocumab)

Table 5. Major Players of Bococizumab

Table 6. Major Players of Others

Table 7. Global PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)

Table 8. Global PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

Table 9. Global PCSK9 Inhibitors Revenue by Type (2017-2022) & ($ million)

Table 10. Global PCSK9 Inhibitors Revenue Market Share by Type (2017-2022)

Table 11. Global PCSK9 Inhibitors Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)

Table 13. Global PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Table 14. Global PCSK9 Inhibitors Revenue by Application (2017-2022)

Table 15. Global PCSK9 Inhibitors Revenue Market Share by Application (2017-2022)

Table 16. Global PCSK9 Inhibitors Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global PCSK9 Inhibitors Sales by Company (2020-2022) & (K Units)

Table 18. Global PCSK9 Inhibitors Sales Market Share by Company (2020-2022)

Table 19. Global PCSK9 Inhibitors Revenue by Company (2020-2022) ($ Millions)

Table 20. Global PCSK9 Inhibitors Revenue Market Share by Company (2020-2022)

Table 21. Global PCSK9 Inhibitors Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers PCSK9 Inhibitors Producing Area Distribution and Sales Area

Table 23. Players PCSK9 Inhibitors Products Offered

Table 24. PCSK9 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global PCSK9 Inhibitors Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global PCSK9 Inhibitors Sales Market Share Geographic Region (2017-2022)

Table 29. Global PCSK9 Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global PCSK9 Inhibitors Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global PCSK9 Inhibitors Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global PCSK9 Inhibitors Sales Market Share by Country/Region (2017-2022)

Table 33. Global PCSK9 Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global PCSK9 Inhibitors Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)

Table 36. Americas PCSK9 Inhibitors Sales Market Share by Country (2017-2022)

Table 37. Americas PCSK9 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas PCSK9 Inhibitors Revenue Market Share by Country (2017-2022)

Table 39. Americas PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)

Table 40. Americas PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

Table 41. Americas PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)

Table 42. Americas PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Table 43. APAC PCSK9 Inhibitors Sales by Region (2017-2022) & (K Units)

Table 44. APAC PCSK9 Inhibitors Sales Market Share by Region (2017-2022)

Table 45. APAC PCSK9 Inhibitors Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC PCSK9 Inhibitors Revenue Market Share by Region (2017-2022)

Table 47. APAC PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)

Table 48. APAC PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

Table 49. APAC PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)

Table 50. APAC PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Table 51. Europe PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)

Table 52. Europe PCSK9 Inhibitors Sales Market Share by Country (2017-2022)

Table 53. Europe PCSK9 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe PCSK9 Inhibitors Revenue Market Share by Country (2017-2022)

Table 55. Europe PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)

Table 56. Europe PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

Table 57. Europe PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)

Table 58. Europe PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa PCSK9 Inhibitors Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa PCSK9 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa PCSK9 Inhibitors Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa PCSK9 Inhibitors Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of PCSK9 Inhibitors

Table 68. Key Market Challenges & Risks of PCSK9 Inhibitors

Table 69. Key Industry Trends of PCSK9 Inhibitors

Table 70. PCSK9 Inhibitors Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. PCSK9 Inhibitors Distributors List

Table 73. PCSK9 Inhibitors Customer List

Table 74. Global PCSK9 Inhibitors Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global PCSK9 Inhibitors Sales Market Forecast by Region

Table 76. Global PCSK9 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global PCSK9 Inhibitors Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas PCSK9 Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas PCSK9 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC PCSK9 Inhibitors Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC PCSK9 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe PCSK9 Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe PCSK9 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa PCSK9 Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa PCSK9 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global PCSK9 Inhibitors Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global PCSK9 Inhibitors Sales Market Share Forecast by Type (2023-2028)

Table 88. Global PCSK9 Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global PCSK9 Inhibitors Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global PCSK9 Inhibitors Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global PCSK9 Inhibitors Sales Market Share Forecast by Application (2023-2028)

Table 92. Global PCSK9 Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global PCSK9 Inhibitors Revenue Market Share Forecast by Application (2023-2028)

Table 94. Amgen Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 95. Amgen PCSK9 Inhibitors Product Offered

Table 96. Amgen PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Amgen Main Business

Table 98. Amgen Latest Developments

Table 99. Eli Lilly Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 100. Eli Lilly PCSK9 Inhibitors Product Offered

Table 101. Eli Lilly PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Eli Lilly Main Business

Table 103. Eli Lilly Latest Developments

Table 104. Sanofi Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 105. Sanofi PCSK9 Inhibitors Product Offered

Table 106. Sanofi PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Sanofi Main Business

Table 108. Sanofi Latest Developments

Table 109. Pfizer Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 110. Pfizer PCSK9 Inhibitors Product Offered

Table 111. Pfizer PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Pfizer Main Business

Table 113. Pfizer Latest Developments

Table 114. Novartis Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 115. Novartis PCSK9 Inhibitors Product Offered

Table 116. Novartis PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Novartis Main Business

Table 118. Novartis Latest Developments

Table 119. Roche Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 120. Roche PCSK9 Inhibitors Product Offered

Table 121. Roche PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Roche Main Business

Table 123. Roche Latest Developments

Table 124. Merck Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck PCSK9 Inhibitors Product Offered

Table 126. Merck PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Merck Main Business

Table 128. Merck Latest Developments

Table 129. Alnylam Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 130. Alnylam PCSK9 Inhibitors Product Offered

Table 131. Alnylam PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Alnylam Main Business

Table 133. Alnylam Latest Developments

Table 134. AstraZeneca Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 135. AstraZeneca PCSK9 Inhibitors Product Offered

Table 136. AstraZeneca PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. AstraZeneca Main Business

Table 138. AstraZeneca Latest Developments

Table 139. Affiris Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 140. Affiris PCSK9 Inhibitors Product Offered

Table 141. Affiris PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Affiris Main Business

Table 143. Affiris Latest Developments

Table 144. BMS Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 145. BMS PCSK9 Inhibitors Product Offered

Table 146. BMS PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. BMS Main Business

Table 148. BMS Latest Developments

Table 149. Ionis Pharmaceuticals Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 150. Ionis Pharmaceuticals PCSK9 Inhibitors Product Offered

Table 151. Ionis Pharmaceuticals PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Ionis Pharmaceuticals Main Business

Table 153. Ionis Pharmaceuticals Latest Developments

Table 154. Cyon Therapeutics Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 155. Cyon Therapeutics PCSK9 Inhibitors Product Offered

Table 156. Cyon Therapeutics PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Cyon Therapeutics Main Business

Table 158. Cyon Therapeutics Latest Developments

Table 159. Daiichi Sankyo Basic Information, PCSK9 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 160. Daiichi Sankyo PCSK9 Inhibitors Product Offered

Table 161. Daiichi Sankyo PCSK9 Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Daiichi Sankyo Main Business

Table 163. Daiichi Sankyo Latest Developments

List of Figures

Figure 1. Picture of PCSK9 Inhibitors

Figure 2. PCSK9 Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PCSK9 Inhibitors Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global PCSK9 Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. PCSK9 Inhibitors Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Epatha(Evolocumab)

Figure 10. Product Picture of Praluent(Alirocumab)

Figure 11. Product Picture of Bococizumab

Figure 12. Product Picture of Others

Figure 13. Global PCSK9 Inhibitors Sales Market Share by Type in 2021

Figure 14. Global PCSK9 Inhibitors Revenue Market Share by Type (2017-2022)

Figure 15. PCSK9 Inhibitors Consumed in Clinical Application

Figure 16. Global PCSK9 Inhibitors Market: Clinical Application (2017-2022) & (K Units)

Figure 17. PCSK9 Inhibitors Consumed in Drug Development

Figure 18. Global PCSK9 Inhibitors Market: Drug Development (2017-2022) & (K Units)

Figure 19. PCSK9 Inhibitors Consumed in Other

Figure 20. Global PCSK9 Inhibitors Market: Other (2017-2022) & (K Units)

Figure 21. Global PCSK9 Inhibitors Sales Market Share by Application (2017-2022)

Figure 22. Global PCSK9 Inhibitors Revenue Market Share by Application in 2021

Figure 23. PCSK9 Inhibitors Revenue Market by Company in 2021 ($ Million)

Figure 24. Global PCSK9 Inhibitors Revenue Market Share by Company in 2021

Figure 25. Global PCSK9 Inhibitors Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global PCSK9 Inhibitors Revenue Market Share by Geographic Region in 2021

Figure 27. Global PCSK9 Inhibitors Sales Market Share by Region (2017-2022)

Figure 28. Global PCSK9 Inhibitors Revenue Market Share by Country/Region in 2021

Figure 29. Americas PCSK9 Inhibitors Sales 2017-2022 (K Units)

Figure 30. Americas PCSK9 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 31. APAC PCSK9 Inhibitors Sales 2017-2022 (K Units)

Figure 32. APAC PCSK9 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 33. Europe PCSK9 Inhibitors Sales 2017-2022 (K Units)

Figure 34. Europe PCSK9 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa PCSK9 Inhibitors Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa PCSK9 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 37. Americas PCSK9 Inhibitors Sales Market Share by Country in 2021

Figure 38. Americas PCSK9 Inhibitors Revenue Market Share by Country in 2021

Figure 39. United States PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC PCSK9 Inhibitors Sales Market Share by Region in 2021

Figure 44. APAC PCSK9 Inhibitors Revenue Market Share by Regions in 2021

Figure 45. China PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 49. India PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe PCSK9 Inhibitors Sales Market Share by Country in 2021

Figure 52. Europe PCSK9 Inhibitors Revenue Market Share by Country in 2021

Figure 53. Germany PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 54. France PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa PCSK9 Inhibitors Sales Market Share by Country in 2021

Figure 59. Middle East & Africa PCSK9 Inhibitors Revenue Market Share by Country in 2021

Figure 60. Egypt PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country PCSK9 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of PCSK9 Inhibitors in 2021

Figure 66. Manufacturing Process Analysis of PCSK9 Inhibitors

Figure 67. Industry Chain Structure of PCSK9 Inhibitors

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles